Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 343

1.

Hepatitis B immune memory in children primed with hexavalent vaccines and given monovalent booster vaccines: an open-label, randomised, controlled, multicentre study.

Zanetti AR, Romanò L, Giambi C, Pavan A, Carnelli V, Baitelli G, Malchiodi G, Valerio E, Barale A, Marchisio MA, Montù D, Tozzi AE, D'Ancona F; study group..

Lancet Infect Dis. 2010 Nov;10(11):755-61. doi: 10.1016/S1473-3099(10)70195-X.

PMID:
20884297
2.

Challenge with a hepatitis B vaccine in two cohorts of 4-7-year-old children primed with hexavalent vaccines: an open-label, randomised trial in Italy.

Zanetti A, Parlato A, Romanò L, Desole MG, Ferrera G, Giurdanella F, Zuliani M, Richard P, Thomas S, Fiquet A.

Vaccine. 2012 Aug 24;30(39):5770-5. doi: 10.1016/j.vaccine.2012.06.078.

PMID:
22789511
3.

A cohort study to evaluate persistence of hepatitis B immunogenicity after administration of hexavalent vaccines.

Giambi C, Bella A, Barale A, Montù D, Marchisio M, Oddone M, Zito S, Rapicetta M, Chionne P, Madonna E, Ciofi degli Atti ML.

BMC Infect Dis. 2008 Jul 28;8:100. doi: 10.1186/1471-2334-8-100.

4.
5.
6.

DTPa-HBV-IPV/Hib Vaccine (Infanrix hexa): A Review of its Use as Primary and Booster Vaccination.

Dhillon S.

Drugs. 2010 May 28;70(8):1021-58. doi: 10.2165/11204830-000000000-00000. Review.

PMID:
20481658
8.

Immune memory to hepatitis B virus in 4-9-year old children vaccinated in infancy with four doses of hexavalent DTPa-HBV-IPV/Hib vaccine.

Zinke M, Kappes R, Kindler K, Paulus-Koschik A, Goering U, Disselhoff J, Soemantri P, Grunert D, Laakmann KH, Gunasekaran R, Gartner B, Jacquet JM.

Hum Vaccin. 2009 Sep;5(9):592-8.

PMID:
19535920
9.

Immunogenicity and safety of a new liquid hexavalent combined vaccine compared with separate administration of reference licensed vaccines in infants.

Mallet E, Fabre P, Pines E, Salomon H, Staub T, Schödel F, Mendelman P, Hessel L, Chryssomalis G, Vidor E, Hoffenbach A; Hexavalent Vaccine Trial Study Group..

Pediatr Infect Dis J. 2000 Dec;19(12):1119-27.

PMID:
11144370
10.

Spotlight on DTPa-HBV-IPV/Hib Vaccine (Infanrix hexa).

Dhillon S.

BioDrugs. 2010 Oct 1;24(5):299-302. doi: 10.2165/11206690-000000000-00000. Review.

PMID:
20795752
12.

Immunological persistence in 5 y olds previously vaccinated with hexavalent DTPa-HBV-IPV/Hib at 3, 5, and 11 months of age.

Silfverdal SA, Assudani D, Kuriyakose S, Van Der Meeren O.

Hum Vaccin Immunother. 2014;10(10):2795-8. doi: 10.4161/21645515.2014.970494.

PMID:
25483640
13.

Low hepatitis B immunogenicity of a hexavalent vaccine widely used in Germany: results of the German Health Survey for Children and Adolescents, 2003-2006.

Jorgensen P, Poethko-Müller C, Hellenbrand W, Jilg W, Thierfelder W, Meyer C, an der Heiden M, Schlaud M, Radun D.

Epidemiol Infect. 2010 Nov;138(11):1621-9. doi: 10.1017/S0950268810000543.

PMID:
20233496
14.

Loss of antibodies, but not of protection.

Wenzel JJ, Jilg W.

Lancet Infect Dis. 2010 Nov;10(11):738-9. doi: 10.1016/S1473-3099(10)70217-6. No abstract available.

PMID:
21029981
15.

Switched memory B cells maintain specific memory independently of serum antibodies: the hepatitis B example.

Rosado MM, Scarsella M, Pandolfi E, Cascioli S, Giorda E, Chionne P, Madonne E, Gesualdo F, Romano M, Ausiello CM, Rapicetta M, Zanetti AR, Tozzi A, Carsetti R.

Eur J Immunol. 2011 Jun;41(6):1800-8. doi: 10.1002/eji.201041187.

16.

Booster hepatitis B vaccination not necessary for long-term protection in children immunised with hexavalent vaccines.

Romanò L, Zanetti AR.

J Prev Med Hyg. 2011 Jun;52(2):45-6. No abstract available.

PMID:
21842704
17.

Immunogenicity and safety of a DTaP-IPV//PRP-T vaccine (Pentaxim) booster during the second year of life in Thai children primed with an acellular pertussis combined vaccine.

Thisyakorn U, Pancharoen C, Chuenkitmongkol S, Ortiz E.

Southeast Asian J Trop Med Public Health. 2009 Mar;40(2):282-94.

PMID:
19323013
18.

A liquid hexavalent combined vaccine against diphtheria, tetanus, pertussis, poliomyelitis, Haemophilus influenzae type B and hepatitis B: review of immunogenicity and safety.

Mallet E, Belohradsky BH, Lagos R, Gothefors L, Camier P, Carrière JP, Kanra G, Hoffenbach A, Langue J, Undreiner F, Roussel F, Reinert P, Flodmark CE, Stojanov S, Liese J, Levine MM, Muñoz A, Schödel F, Hessel L; Hexavalent Vaccine Trial Study Group..

Vaccine. 2004 Mar 29;22(11-12):1343-57. Review.

PMID:
15063556
19.

Lasting immune memory against hepatitis B in children after primary immunization with 4 doses of DTPa-HBV-IPV/Hib in the first and 2nd year of life.

Steiner M, Ramakrishnan G, Gartner B, Van Der Meeren O, Jacquet JM, Schuster V.

BMC Infect Dis. 2010 Jan 15;10:9. doi: 10.1186/1471-2334-10-9.

20.

Hepatitis B specific T cell immunity induced by primary vaccination persists independently of the protective serum antibody level.

Carollo M, Palazzo R, Bianco M, Pandolfi E, Chionne P, Fedele G, Tozzi AE, Carsetti R, Romanò L, Ausiello CM.

Vaccine. 2013 Jan 7;31(3):506-13. doi: 10.1016/j.vaccine.2012.11.029.

PMID:
23174200
Items per page

Supplemental Content

Support Center